¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"proserum prothrombin conversion accelerator"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
¿µ¹® linear accelerator ÇÑ±Û ¼±»ó°¡¼Ó±â
¼³¸í   
  Ä¡·á¹æ»ç¼±°ú¿¡¼­ ÀÌ¿ëÇϴ ±â°è·Î¼­ ÀüÀÚ¸¦ »ý¼ºÇØ ³½´Ù. ÀüÀڴ ´Ü¼øÈ÷ X-¼±°ú´Â ´Ù¸¥ °ÍÀ¸·Î ÀüÀÚ°¡ ±Ý¼Ó¿¡ ºÎµúÇô ³ª¿À´Â °ÍÀÌ X-¼±ÀÌ´Ù. ÀüÀڴ Áø´Ü¸ñÀûº¸´Ù´Â Ä¡·á¸ñÀûÀ¸·Î ÁַΠÇǺÎÀÇ ¾Ç¼ºÁ¾¾ç(¾Ï)¿¡ »ç¿ëµÈ´Ù.
¿µ¹® prothrombin time ÇÑ±Û ÇÁ·ÎÆ®·Òºó½Ã°£
¼³¸í   
  ÇÁ·ÎÆ®·ÒºóÀº °£¿¡¼­ ÇÕ¼ºµÇ´Â ºñŸ¹Î K ÀÇÁ¸¼º ÀÀ°í´Ü¹éÁúÀÇ ÇϳªÀ̸ç, ÇÁ·ÎÆ®·Òºó½Ã°£Àº ¿ÜÀΰè ÀÀ°íȰ¼ºÀ» Á¾ÇÕÀûÀ¸·Î Æ¯Á¤Çϴ °Ë»çÀÇ ÇϳªÀÌ´Ù. ÇǰËÇ÷Àå¿¡ Ä®½·À̿°ú Á¶Á÷Æ®·Òº¸ÇÃ¶ó½ºÆ¾(Á¦III ÀÀ°íÀÎÀÚ)À» °¡ÇØ, ¼¶À¯¼Ò°¡ ³ªÅ¸³¯ ¶§±îÁöÀÇ ½Ã°£À¸ ÃøÁ¤ÇÑ´Ù.
¿µ¹® conversion ÇÑ±Û Àüȯ
¼³¸í   
  1. ³»ºÎÀÇ °¥µî¿¡ ´ëÇÑ ¹«ÀǽÄÀû ¹æ¾î¸ÞÄ¿´ÏÁòÀ¸·Î ³»ºÎÀÇ °¥µîÀ» Æ¯Á¤ÇÑ ½ÅüÀÇ Áõ»óÀ¸·Î º¯È¯ÇÏ¿© ³ªÅ¸³»´Â °Í. 2. ¾î¶² º´À̳ª ¹ÝÀÀÀÌ ÇÑ »óÅ¿¡¼­ ´Ù¸¥ »óÅ·Πº¯Çϴ °Í.
¿µ¹® conversion disorder ÇÑ±Û ÀüȯÀå¾Ö
¼³¸í   
  ³»ºÎÀÇ °¥µî¿¡ ´ëÇÑ ¹«ÀǽÄÀû ¹æ¾î¸ÞÄ¿´ÏÁòÀ¸·Î ³»ºÎÀÇ °¥µîÀ» Æ¯Á¤ÇÑ ½ÅüÀÇ Áõ»óÀ¸·Î º¯È¯ÇÏ¿© ³ªÅ¸³»´Â °ÍÀ» ¸» ÇÑ´Ù. ÀÌ ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ» ÁַΠ³ªÅ¸³»´Â Á¤½ÅÁúȯÀ» ÀüȯÀå¾Ö¶ó°í ÇÑ´Ù. ÀüȯÀ¸·Î ÀÎÇÑ Áõ»óÀ¸·Î ´ëÇ¥ÀûÀΠ°ÍÀ¸·Î´Â ¸¶ºñ, °æ·Ã, ÀǽÄÀå¾Ö µîÀÌ´Ù. ´ë°³ ±× º´À» ÀÏÀ¸Å³ ¸¸ÇÑ º´º¯ÀÌ Á¸ÀçÇÏÁö ¾Ê°í, ½É¸®Àû °¥µîÀÌ ½ÉÇÒ °æ¿ì¿¡ ´õ¿í Áõ»óÀÌ ½ÉÇØÁö°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇØ¼­ ³»ºÎÀû °¥µîÀÌ °¨¼ÒµÇ°í Áõ»óÀÇ ¹ßÇöÀ¸·Î ÀÎÇÑ 2Â÷Àû À̵æ(°¡Á·µéÀÇ °ü½ÉÁýÁß, µ¹ºÁÁÜ)ÀÌ Àִ °ÍÀÌ ÀÌ ÀüȯÀå¾ÖÀǠƯ¡ÀÌ´Ù. ´ë°³ ÀÌ ÀüȯÀå¾Ö È¯Àڴ ÀÚ½ÅÀÇ Áúȯ¿¡ ´ëÇØ¼­ Æ¯Â¡ÀûÀ¸·Î ¸Å¿ì ¹«°ü½ÉÇѠŵµ¸¦ ÃëÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • prothrombin
    ÇÁ·ÎÆ®·Òºó
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • accelerator
    1. ÃËÁøÀÎÀÚ, ÃËÁøÁ¦ 2. °¡¼Ó±â
  • accelerator nerve
    ÃËÁø½Å°æ
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • particle accelerator
    ÀÔÀÚ°¡¼Ó±â
  • reaction accelerator
    ¹ÝÀÀÃËÁøÁ¦
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • conversion
    Àüȯ
  • conversion disorder
    ÀüȯÀå¾Ö
  • conversion factor
    º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
  • conversion heat
    Àüȯ¿­
  • conversion neurosis
    Àüȯ½Å°æÁõ
  • conversion rate
    ÀüȯÀ²
  • conversion reaction
    Àüȯ¹ÝÀÀ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerator
    1. ÃËÁøÀÎÀÚ, ÃËÁøÁ¦, 2. °¡¼Ó±â
  • prothrombin
    ÇÁ·ÎÆ®·Òºó
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • conversion
    Àüȯ
  • peripheral conversion
    ¸»ÃÊÀüȯ
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • prothrombin
    ÇÁ·ÎÆ®·Òºó
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • accelerator
    ÃËÁøÀÎÀÚ, ÃËÁøÁ¦, °¡¼Ó±â
  • accelerator nerve
    ÃËÁø½Å°æ
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • particle accelerator
    ÀÔÀÚ°¡¼Ó±â
  • reaction accelerator
    ¹ÝÀÀÃËÁøÃ¼
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • conversion
    Àüȯ
  • congenital conversion nipple
    ¼±ÃµÀüȯÀ¯µÎ
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • conversion factor
    º¯È¯ÀÎÀÚ, º¯È¯°è¼ö
  • conversion heat
    Àüȯ¿­
  • conversion neurosis
    Àüȯ½Å°æÁõ
  • conversion rate
    ÀüȯÀ²
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • SPCA= serum prothrombin conversion a
    Ç÷ûÇÁ·ÎÆ®·ÒºóÀüÈ­ÃËÁø¼Ò.
  • accelerator
    ÃËÁøÀÎÀÚ(õµòäì×í­), ÃËÁøÁ¦
  • accelerator
    °¡¼Ó±â, ÃËÁøÁ¦
  • accelerator nerve
    ÃËÁø½Å°æ(õµòäãêÌè).
  • reaction accelerator
    ¹ÝÀÀÃËÁøÃ¼(Úãëë õµòäô÷).
  • activated partial prothrombin time
    Ȱ¼º ºÎºÐÇÁ·ÎÆ®·Òºó½Ã°£
  • plasma prothrombin time
    Ç÷ÀåÇÁ·ÎÆ®·Òºó ½Ã°£.
  • prothrombin
    ÇÁ·ÎÆ®·Òºó.
  • prothrombin
    ÇÁ·ÎÆ®·Òºó
  • prothrombin complex concentrates
    ÇÁ·ÎÆ®·Òºó º¹ÇÕ ³óÃà(¹°)
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£.
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó ½Ã°£
  • absorbed dose conversion factor
    Èí¼ö¼±·®º¯È¯°è¼ö
  • gene conversion
    À¯ÀüÀÚº¯È¯.
  • gene conversion
    À¯ÀüÀÚº¯È¯(ܨüµ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • serum prothrombin conversion accelera
    Ç÷ûÇÁ·ÎÆ®·ÒºóÀüȯÃËÁø¼Ò(úìôè¡­ï®üµõµòä
  • accelerator
    °¡¼Ó±â, ÃËÁøÁ¦
  • accelerator
    ÃËÁøÀÎÀÚ(õµòäì×í­), ÃËÁøÁ¦
  • accelerator nerve
    ÃËÁø½Å°æ(õµòäãêÌè).
  • augmentor nerve =accelerator n.
    ÃËÁø½Å°æ.
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • linear accelerator
    ¼±Çü°¡¼Ó±â(¡­Ê¥áÜÐï).
  • particle accelerator
    ÀÔÀÚ°¡¼Ó±â
  • reaction accelerator
    ¹ÝÀÀÃËÁøÃ¼(Úãëë õµòäô÷).
  • activated partial prothrombin time
    Ȱ¼º ºÎºÐÇÁ·ÎÆ®·Òºó½Ã°£
  • factor ii(prothrombin)
    Á¦2ÀÎÀÚ(ÇÁ·ÎÆ®·Òºó)
  • partial prothrombin time
    ºÎºÐÇÁ·ÎÆ®·Òºó½Ã°£
  • plasma prothrombin time
    Ç÷ÀåÇÁ·ÎÆ®·Òºó ½Ã°£.
  • prothrombin
    ÇÁ·ÎÆ®·Òºó.
  • prothrombin
    ÇÁ·ÎÆ®·Òºó
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • egg negative conversion rate
    Ãæ¶õÀ½ÀüÀ²
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • precursor of serum prothrombin conversion accelerator
    Ç÷û(úìôè)ÇÁ·ÎÆ®·Òºó Àüȯ°¡¼ÓÁ¦ Àü±¸¹°Áú(ï®üµÊ¥áÜð¥îñÏÌÚªòõ)
  • serum prothrombin conversion accelerator
    Ç÷û(úìôè) ÇÁ·ÎÆ®·Òºó ÀüȯÃËÁøÁ¦(ï®üµõµòäð¥)
  • accelerator
    °¡¼Ó±â (Ê¥áÜÐï)
  • accelerator globulin
    ÃËÁø (õµòä) ±Û·ÎºÒ¸°
  • accelerator protein
    ÃËÁø´Ü¹éÁú (õµòäÓ±ÛÜòõ)
  • linear accelerator
    ¼±Çü°¡¼Ó±â(àÊû¡Ê¥áÜѦ)
  • prothrombin
    ÇÁ·ÎÆ®·Òºó
  • prothrombin derivatives theory
    ÇÁ·ÎÆ®·Òºó À¯µµÃ¼ ÀÌ·Ð(ë¯Óôô÷×âÖå)
  • prothrombin factor
    ÇÁ·ÎÆ®·Òºó ÀÎÀÚ(ì×í­)
  • serum prothrombin converting factor
    Ç÷û(úìôè) ÇÁ·ÎÆ®·Òºó ÀüȯÀÎÀÚ(ï®üµì×í­)
  • antigenic conversion
    Ç׿øÀüȯ(ù÷ê«ï®üµ)
  • conversion
    Àüȯ(ï®üµ)
  • conversion coefficient
    Àüȯ°è¼ö(ï®üµÌõâ¦)
  • conversion electron
    ÀüȯÀüÀÚ(ï®üµï³í­)
  • conversion factor
    ÀüȯÀÎÀÚ(ï®üµì×í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • prothrombin time
    ÇÁ·ÎÆ®·Òºó½Ã°£
  • conversion
    Àüȯ, º¯È¯, º¯Á¶, ÀüÈ­
  • conversion factor
    º¯È¯ÀÎÀÚ
  • digital scan conversion
    µðÁöÅнºÄµº¯È¯
  • direct conversion x-ray detector
    Á÷Á¢º¯È¯X¼±°ËÃâ±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PPCA plasma prothrombin conversion accelerator; proserum prothrombin conversion accelerator
SPCA serum prothrombin conversion accelerator; Society for Prevention of Cruelty to Animals
PCF peripheral circulatory failure; pharyngoconjunctival fever; platelet complement fixation; posterior ...
PPC pentose phosphate cycle; peripheral posterior curve; plasma prothrombin conversion; pneumopericardiu...
PPCF peripartum cardiac failure; plasma prothrombin conversion factor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AMS Accelerator Mass Spectrometry
LINAC Linear Accelerator
(14)C Conversion of
1-14C Conversion of
4-14C Conversion of
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • accelerator
    ÃËÁø ÀÎÀÚ, ÃËÁøÁ¦, ÃËÁø ¹°Áú, ÃËÁø½Å°æ, Ȱ¼ºÁ¦
    1. ¹°Ã¼ÀÇ ÁøÇà, ¹°ÁúÀÇ È°µ¿ ¶Ç´Â ¾î¶² ¹ÝÀÀÀÌ ÀϾ´Â ¼Óµµ¸¦ Áõ°¡½Ã۱â À§Çؼ­ »ç¿ëµÇ´Â ¹°ÁúÀ̳ª ÀåÄ¡. 2. ±â´ÉÀÇ ¼öÇàÀ» ºü¸£°Ô ÇÏ´Â ½Å°æÀ̳ª ±ÙÀ°. 3. °í¹«ÀÇ °æÈ­ ¶Ç´Â ±× ¿ÜÀÇ ÁßÇÕ¿¡ »ç¿ëµÇ´Â ÀÏ·ÃÀÇ È­ÇÐ ¹°Áú·Î¼­ ÀÛ¾÷ÀÚ¿¡°Ô ÇǺο°À» ÀÚÁÖ ÀÏÀ¸Å²´Ù. 4. È­ÇйÝÀÀÀ» °¡¼ÓÈ­½ÃŰ´Â ¹°Áú 5. »ý¸®ÇÐÀûÀ¸·Î ¿îµ¿À̳ª ¹ÝÀÀÀ» ºü¸£°Ô ÇÏ´Â ½Å°æ, ±ÙÀ°, ȤÀº ¹°Áú. 6. Àú¿Â¿¡¼­ ÁßÇÕÀ» °³½Ã½ÃŰ´Â ÀÛ¿ëÀ» °®´Â ¹°Áú. ÁßÇÕÃ˸Š¶Ç´Â ÃËÁøÁ¦¶ó°íµµ ÇÑ´Ù. 7. ¹ÝÀÀÀ» ´õ¿í ÃËÁøÇϱâ À§ÇÑ ¾àÁ¦.
  • ultra-accelerator
    ÃÊÃËÁøÁ¦
  • partial prothrombin time
    ºÎºÐ ÇÁ·ÎÆ®·Òºó ½Ã°£
  • plasma prothrombin time
    Ç÷Àå ÇÁ·ÎÆ®·Òºó ½Ã°£
  • prothrombin consumption test
    ÇÁ·ÎÆ®·Òºó ¼Òºñ ½ÃÇè
    ³»Àμº Æ®·Òº¸ÇÃ¶ó½ºÆ¾ÀÇ Çü¼º·® ÃøÁ¤À» ÁÖµÈ ¸ñÀûÀ¸·Î ÇÏ´Â ½ÃÇèÀ¸·Î, ÀÀÇ÷ ¿Ï·á ÈÄ¿¡ ³²¾Æ ÀÖ´Â Ç÷û ÇÁ·ÎÆ®·ÒºóÀ» ÃøÁ¤ÇÑ´Ù. ÀÌ ½ÃÇèÀº Àüü Ç÷¾×¿¡ ´ëÇÏ¿© ÇàÇϱ⠶§¹®¿¡, Ç÷¼ÒÆÇÀÇ ÀÀÇ÷ ±â´É ÃøÁ¤¿¡ °£Á¢ÀûÀ¸·Î »ç¿ëµÈ´Ù.
  • prothrombin test
    ÇÁ·ÎÆ®·Òºó ½ÃÇè
    ÀÀÇ÷ ½Ã°£¿¡ ±âÃÊÇÑ ÇÁ·ÎÆ®·Òºó °ËÃâ ½ÃÇè.
  • two-stage prothrombin test
    ÀÌ ´Ü°è ÇÁ·ÎÆ®·Òºó ½ÃÇè
  • absorbed dose conversion factor
    Èí¼ö¼±·® º¯È¯ °è¼ö
  • conversion disorder
    Àüȯ Àå¾Ö
    1. ±âÁúÀû ÁúȯÀÌ ¾øÀÌ ¹«ÀǽÄÀûÀÎ ¿ä±¸³ª °¥µîÀ¸·Î ÀÎÇÑ °¨°¢À̳ª ¿îµ¿ ±â´ÉÀÇ Àå¾Ö°¡ Ư¡ÀÎ Á¤½Å Áúȯ. 2. ½Å°æÇÐÀû ¶Ç´Â ³»°úÀû ÁúȯÀÌ ¾øÀÌ ¸¶ºñ, ½Ã·Â »ó½Ç, ÇÔ±¸Áõ
  • conversion factor
    º¯È¯ °è¼ö
  • conversion rate
    ÀüȯÀ²
  • hysteria conversion
    Àüȯ È÷½ºÅ׸®, È÷½ºÅ׸® Àüȯ
    ºÒ¾ÈÀ» ½ÅüÀû ¡ÈÄ ¶Ç´Â Áõ»óÀ¸·Î Àüȯ½ÃÄÑ, ºÒ¾ÈÀ» ¹Ù²Ù¾î ³õ´Â °ÍÀ» Ư¡À¸·Î ÇÏ´Â È÷½ºÅ׸®.
  • salt water conversion kit
    ¿°·ù º¯È¯ Ŷ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
proserum prothrombin conversion accelerator A coagulation (clotting) factor. Classic haemophilia (haemophilia A) is due to a congenital deficiency in the amount (or activity) of factor VIII. Factor VIII is also known as antihemophiliac factor (AHF) or antihemophiliac globulin (AHG). The gene for factor VIII (that for classic haemophilia) is on the X chromosome so females can be silent carriers without symptoms and males can be haemophiliacs.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
serum prothrombin conversion accelerator <chemical> Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor viia in the extrinsic pathway of blood coagulation. The activated form then catalyses the activation of factor x to factor xa.
Chemical name: Blood-coagulation factor VII
(12 Dec 1998)
prothrombin accelerator <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease.
Chemical name: Blood-coagulation factor V
(12 Dec 1998)
prothrombin Clotting Factor II.
Origin: Gr. Thrombos = cloth in
(18 Nov 1997)
prothrombin and proconvertin test A test formerly used by some to control anticoagulant therapy with bishydroxycoumarin and indandione drugs.
Synonym: P and P test.
(05 Mar 2000)
prothrombin deficiency A congenital or acquired disorder of blood clotting where there is a deficiency of factor II (prothrombin), one of 20 necessary plasma proteins for normal blood coagulation. Acquired factor II deficiency may result from vitamin K deficiency, severe liver disease and anticoagulant drugs.
Symptoms include abnormal bleeding, nosebleeds, abnormal menstrual bleeding, easy bruising and umbilical cord bleeding at birth. Treatment involves the infusion of fresh frozen plasma. Vitamin K may be administered in select cases.
(27 Sep 1997)
prothrombin test A quantitative test for prothrombin in the blood based on the clotting time of oxalated blood plasma in the presence of thromboplastin and calcium chloride; measures the integrity of the extrinsic and common pathways of coagulation.
See: prothrombin time.
Synonym: Quick's method, Quick's test.
(05 Mar 2000)
prothrombin time Measurement of clotting time of plasma recalcified in the presence of excess tissue thromboplastin. Factors measured are fibrinogen, prothrombin, and factors v, vii, and x. It is used for monitoring anticoagulant therapy with coumarins.
(12 Dec 1998)
accelerator 1. Anything that increases rapidity of action or function.
2. In physiology, a nerve, muscle, or substance that quickens movement or response.
3. A catalytic agent used to hasten a chemical reaction.
4. In nuclear physics, a device that accelerates charged particles (e.g., protons) to high speed in order to produce nuclear reactions in a target, often for the production of radionuclides or for radiation therapy.
Synonym: accelerant.
Origin: L. Accelerans, pres. P. Of ac-celero, to hasten, fr. Celer, swift
(05 Mar 2000)
accelerator factor <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease.
Chemical name: Blood-coagulation factor V
(12 Dec 1998)
accelerator fibres Postganglionic sympathetic nerve fibre's originating in the superior, middle, and inferior cervical ganglia of the sympathetic trunk, conveying nervous impulses to the heart that increase the rapidity and force of the cardiac pulsations.
Synonym: augmentor fibres.
(05 Mar 2000)
accelerator globulin Globulin in serum that promotes the conversion of prothrombin to thrombin in the presence of thromboplastin and ionised calcium.
See: factor Va, factor V, serum accelerator globulin.
(05 Mar 2000)
accelerator nerves Certain of the cardiopulmonary splanchnic nerves establishing the sympathetic innervation of the heart; originating from ganglion cells of the superior, middle, and inferior cervical ganglion of the sympathetic trunk, the unmyelinated efferent fibres of the accelerator nerve's stimulate an increase in the heart rate.
(05 Mar 2000)
railgun accelerator <radiobiology> Projectile accelerator which accelerates the particle using electromagnetic forces which arise when the particle completes an electrical circuit between two conducting rails connected to a source of high current.
(09 Oct 1997)
plasma accelerator globulin <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease.
Chemical name: Blood-coagulation factor V
(12 Dec 1998)
serum accelerator <chemical> Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor viia in the extrinsic pathway of blood coagulation. The activated form then catalyses the activation of factor x to factor xa.
Chemical name: Blood-coagulation factor VII
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • prothrombin
    ÇÁ·ÎÆ®·Òºó(ÀÀÇ÷ ÀÎÀÚÀÇ ÀÏÁ¾)
  • accelerator
    °¡¼ÓÀÚ
  • accelerator
    °¡¼ÓÀåÄ¡;ÃËÁøÁ¦
  • induction accelerator
    BETATRON
  • linear accelerator
    ¼±Çü°¡¼Ó±â
  • particle accelerator
    ÀÔÀÚ °¡¼Ó±â
  • conversion
    Àüȯ; ÅÂȯ(ÅÂȯ)
  • conversion
    Àüȯ;ÀüÈ­(changing);(Áý.Â÷µîÀÇ)°³Àå;°³Á¶;º¯¼³;ÀüÇâ;°³Á¾;±ÍÀÇ (ƯÈ÷ ±âµ¶±³¿¡ÀÇ);(ÁÖ»ç¿Í ºó»ç¿ÍÀÇ)ȯÀ§(¹ý);(ºÎäÀÇ) Â÷ȯ;¹Ù²ãÁü;(ÁöÆóÀÇ)ÅÂȯ;(¿Ü±¹ÅëÈ­ÀÇ)ȯ»ê;ÀÌÀÚ¸¦ ¿ø±Ý¿¡ °¡»êÇϱâ;(Àç»êÀÇ)Àüȯ;(µ¿»êÀÇ)Ⱦ·É;Àüȯ(ÇÙ¿¬·á¹°ÁúÀÌ ´Ù¸¥ ÇÙ¿¬·á¹°Áú·Î º¯È­Çϱâ);~al;
  • conversion agent
    Àüȯ ´ë¸® ±â°ü
  • conversion factor
    (¹®ÀÇ.ÀÚ·áû±¸¿¡¼­ ½ÇÁ¦ »óǰ±¸¸ÅÀÎÀ¸·ÎÀÇ)ÀüȯÀ²
  • conversion heater
    Àü¿­±â(electric heater)
  • conversion ratio
    Àüȯ ºñÀ²(Çٺп­½Ã ÇϳªÀÇ ¿øÀÚ¿¡¼­ »ý±â´Â ¿øÀÚÀÇ ¼ö
  • conversion table
    (µµ·®ÇüµîÀÇ)ȯ»êÇ¥
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á